cas 2869955-99-5|| where to buy tert-butyl 4-(1-methoxy-1,3-dioxopentan-2-yl)piperazine-1-carboxylate

Product Name:tert-butyl 4-(1-methoxy-1,3-dioxopentan-2-yl)piperazine-1-carboxylate

IUPAC Name:tert-butyl 4-(1-methoxy-1,3-dioxopentan-2-yl)piperazine-1-carboxylate

Packing Unit	Available Stock	Price($)
CM1078120-100mg	in stock	ǺǠȋ
CM1078120-500mg	in stock	ŭǺƅǠ
CM1078120-1g	in stock	ƏƅƻǺ

For R&D use only.

Inquiry Form

Chemical Name

CAS Number

Quantity*

Required Specifications*
(Assay %, Material Grade etc.)

Contact Name*

Contact Email*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2869955-99-5 regularly via the above email.

Additional Notes

Verification code*

refresh

: CAS NO:2869955-99-5; Molecular Formula:C15H26N2O5; Melting Point:-; Smiles Code:O=C(OC(C)(C)C)N1CCN(CC1)C(C(=O)OC)C(=O)CC; Density:1.130±0.06 g/cm3

: Catalog Number:CM1078120; Molecular Weight:314.38; Boiling Point:397.8±42.0 °C; MDL No:; Storage:

: Piperazines; Piperazine is an organic compound consisting of a six-membered ring containing two nitrogen atoms in opposite positions in the ring. The chemical formula of piperazine is C4H10N2, and it is an important pharmaceutical intermediate. Pyrimidines and piperazines are known to be the backbone of many bulk compounds and important core structures for approved drugs; studies have shown that combining a pyridine ring with a piperazine moiety within a single structural framework enhances biological activity.

: HRO761; Novartis'HRO761 is an oral allosteric inhibitor targeting WRN helicase, aimed at treating microsatellite instability (MSI) or deficient mismatch repair (dMMR) tumors. WRN has emerged as a critical synthetic lethal target in MSI cancers, which are common in colorectal, gastric, endometrial, and ovarian cancers. Although MSI cancers show a high response rate to immune checkpoint inhibitors, many patients develop resistance. By acting on WRN, HRO761 may be able to stop the growth of the cancer.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.